Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study

Background and objectives: The severity of anemia at which to initiate erythropoiesis-stimulating agent (ESA) treatment in nondialysis chronic kidney disease (CKD) patients is unclear. Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis CKD patients with “early...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Seliger, Stephen, Fox, Kathleen M., Gandra, Shravanthi R., Bradbury, Brian, Hsu, Van Doren, Walker, Loreen, Chiou, Chiun-Fang, Fink, Jeffrey C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2010
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863974/
https://ncbi.nlm.nih.gov/pubmed/20299377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07171009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi